United States
US 12,697,349 B2
Compositions and methods for treating RAS-mutant cancers
US 12,697,349 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: ALGEN BIOTECHNOLOGIES, INC.; MEMORIAL SLOAN KETTERING CANCER CENTER. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- ALGEN BIOTECHNOLOGIES, INC.; MEMORIAL SLOAN KETTERING CANCER CENTER
- Inventors
- Chun-Hao HUANG; Spencer Charles KNIGHT; Scott LOWE
- Publication date
- 2026-08-04
- Filing date
- 2021-10-19
- Document type
- B2 Granted patent
- Also written as
- US 12,697,349 B2 · US12697349 · 12697349
Abstract
The present disclosure relates generally to compositions and methods for the treatment of a RAS-mutant cancer. In particular, the present technology relates to administering a therapeutically effective amount of one or more TXNRD1 inhibitors to a subject diagnosed with, or at risk for a RAS-mutant cancer (e.g., RAS-mutant pancreatic cancer).
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free